Logo

Divi's Laboratories Ltd. Share Price

Divi's Laboratories Ltd. (INR)5568.752.1   (0.9%)

Exchange ScripsBSE532488NSEDIVISLABISININE361B01024

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Divi's Laboratories Ltd. Performance

Market performance
Open price5549.95
High5645.95
Volumes280218
Prev Close5568.7
Low5549.95
Closing date2025-03-06
Historical performance
1 Year High6285.45
3 Year High6285.45
5 Year High6285.45
1 Year Low3350.00
3 Year Low2730.00
5 Year Low1626.00

Divi's Laboratories Ltd. Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
148174
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
92.23
Dividend Yield
Dividend Yield
0.27 %

Divi's Laboratories Ltd. Investment Returns

1 Year
57.1%
3 Years
36%
5 Years
148.6%
10 Years
528.3%

Divi's Laboratories Ltd. Technicals

IndicatorsValueSignal
5-DMA5524.69Bullish
10-DMA5640.36Bearish
20-DMA5803.59Bearish
50-DMA5838.94Bearish
100-DMA5886.85Bearish
200-DMA5379.76Bullish

Shareholding Pattern

FieldDec-2024Sep-2024Jun-2024Mar-2024Dec-2023
Promoters66666
Foreign Investors---------------
Domestic Investors66666
Public Investors280595278893298304347623354476
Government321------

Divi's Laboratories Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income339034501159627
Operating Profit25450271403997029237
Interest40202021
Depreciation3780343031152556
Profit Before Tax21630236903683526660
Consolidated Net Profit16000182402960419843
Adjusted EPS606911275

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital530530531531
Total Reserves13518012714011675192415
Minority Interest------------
Total Non-Current Liabilities6110557043653639
Total Liabilities159370148630146191113869
Capital Work in Progress7780212046997106
Total Assets159370148630146191113869

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities12610245901911819469
Cash Flow from Investing Activities-2690-27070-21949751
Cash Flow from Financing Activitie-7990-7970-5324-349
Net Cash Inflow / Outflow1930-10450-815619872
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 92.23.
  • 3Y Stock Price CAGR of the stock is 11.0.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹25450 Million.
  • The company generated revenue of ₹78450 Million in the previous financial year.

Divi's Laboratories Ltd.

5568.752.1   (0.9%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1546173.9
No. of Shares: 277.7
Performance:54.6%
P/L: ₹546173.9
Top Gainers
SymbolChange%
CAPTRUST90.93(20%)
KOHINOOR37.67(18%)
SOMICONVEY154.25(17%)
KECL142.08(16%)
LANCORHOL25.97(16%)
Top Losers
SymbolChange%
GENSOL334.8(-10%)
BBTCL147.13(-6%)
FOODSIN93.85(-6%)
ANSALAPI5.25(-5%)
INFOMEDIA6.12(-5%)
SBGLP32.28(-5%)
RAMANEWS25.28(-5%)
AGSTRA16.25(-5%)
Similar stocks

Glaxosmithkline Pharmaceuticals Ltd.

19

2690.2

February 6 - March 6

Aarti Pharmalabs Ltd.

9.9

746.95

February 6 - March 6

Gland Pharma Ltd.

7.4

1629.95

February 6 - March 6

Abbott India Ltd.

6.5

30983.2

February 6 - March 6

Sanofi Consumer Healthcare India Ltd.

2.3

4813.9

February 6 - March 6

Suven Pharmaceuticals Ltd.

-0.1

1164.6

February 6 - March 6

Cipla Ltd.

-0.7

1461.75

February 6 - March 6

Bafna Pharmaceuticals Ltd.

-1.5

78.47

February 6 - March 6

Announcing Stock of the Month!

Stock of the Month
Stock of the Month